{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T18:43:07Z","timestamp":1777315387741,"version":"3.51.4"},"reference-count":127,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007693","name":"King Chulalongkorn Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","kidneymedicinejournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney Medicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.xkme.2026.101284","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:17:52Z","timestamp":1770398272000},"page":"101284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent, Nonrecurrent, and De Novo Membranous Nephropathy After Kidney Transplantation: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"8","author":[{"given":"Thanyarat","family":"Phumthian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veerapat","family":"Wattanasatja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aschariya","family":"Wipattanakitcharoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thunyatorn","family":"Wuttiputhanun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asada","family":"Leelahavanichkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natavudh","family":"Townamchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingyos","family":"Avihingsanon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4087-9032","authenticated-orcid":false,"given":"Suwasin","family":"Udomkarnjananun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.xkme.2026.101284_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2478\/abm-2024-0015","article-title":"A review of landmark studies on maintenance immunosuppressive regimens in kidney transplantation","volume":"18","author":"Udomkarnjananun","year":"2024","journal-title":"Asian Biomed (Res Rev News)"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/TP.0000000000002918","article-title":"The first Asian kidney transplantation prediction models for long-term patient and allograft survival","volume":"104","author":"Udomkarnjananun","year":"2020","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib3","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/TP.0000000000003012","article-title":"The causes of kidney allograft failure: more than alloimmunity. a viewpoint article","volume":"104","author":"Van Loon","year":"2020","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.xkme.2026.101284_bib4","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1093\/ndt\/gfab345","article-title":"Recurrence of glomerulonephritis after kidney transplant","volume":"37","author":"Alawieh","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.xkme.2026.101284_bib5","first-page":"144","article-title":"Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors","volume":"50","author":"Cosyns","year":"1998","journal-title":"Clin Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2026.101284_bib6","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.ekir.2024.09.012","article-title":"Anti phospholipase A2 receptor 1 antibodies and membranous nephropathy recurrence after kidney transplantation","volume":"9","author":"Cremoni","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"9","key":"10.1016\/j.xkme.2026.101284_bib7","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001357","article-title":"Predictive models for recurrent membranous nephropathy after kidney transplantation","volume":"8","author":"Chung","year":"2022","journal-title":"Transplant Direct"},{"issue":"6","key":"10.1016\/j.xkme.2026.101284_bib8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ajt.2024.01.036","article-title":"Recurrence of membranous nephropathy after kidney transplantation: a multicenter retrospective cohort study","volume":"24","author":"Hullekes","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.xkme.2026.101284_bib9","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.xkme.2026.101284_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"10","key":"10.1016\/j.xkme.2026.101284_bib11","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"4","key":"10.1016\/j.xkme.2026.101284_bib12","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1093\/pubmed\/fdac036","article-title":"Strengthening systematic reviews in public health: guidance in the Cochrane Handbook for Systematic Reviews of Interventions, 2nd edition","volume":"44","author":"Cumpston","year":"2022","journal-title":"J Public Health (Oxf)"},{"issue":"4","key":"10.1016\/j.xkme.2026.101284_bib13","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/0002-9343(82)90453-3","article-title":"Evaluation of recurrent glomerulonephritis in kidney allografts","volume":"72","author":"Morzycka","year":"1982","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.xkme.2026.101284_bib14","first-page":"210","article-title":"Glomerulonephritis in renal allografts: results of 18 years of transplantations","volume":"21","author":"Honkanen","year":"1984","journal-title":"Clin Nephrol"},{"issue":"3","key":"10.1016\/j.xkme.2026.101284_bib15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/00007890-198803000-00004","article-title":"Immunopathologic features of de novo membranous nephropathy in renal allografts","volume":"45","author":"Ward","year":"1988","journal-title":"Transplantation"},{"issue":"8","key":"10.1016\/j.xkme.2026.101284_bib16","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/ndt\/4.8.730","article-title":"Recurrent glomerulonephritis in renal transplants: fourteen years' experience","volume":"4","author":"O\u2019Meara","year":"1989","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0272-6386(12)80493-8","article-title":"Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A","volume":"17","author":"Schwarz","year":"1991","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.xkme.2026.101284_bib18","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00007890-199505150-00009","article-title":"Recurrence of membranous nephropathy after renal transplantation. Incidence and risk factors in 1614 patients","volume":"59","author":"Couchoud","year":"1995","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00007890-199601270-00012","article-title":"The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis","volume":"61","author":"Odorico","year":"1996","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.xkme.2026.101284_bib20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00041552-199711000-00001","article-title":"Glomerular diseases in patients with hepatitis C virus infection after renal transplantation","volume":"6","author":"Morales","year":"1997","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"6","key":"10.1016\/j.xkme.2026.101284_bib21","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/ajkd.1998.v31.pm9631835","article-title":"Recurrent and de novo renal diseases after renal transplantation: a report from the renal allograft disease registry","volume":"31","author":"Hariharan","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00007890-199909150-00007","article-title":"Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR)","volume":"68","author":"Hariharan","year":"1999","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMoa013036","article-title":"Risk of renal allograft loss from recurrent glomerulonephritis","volume":"347","author":"Briganti","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/01.tp.0000188656.44326.53","article-title":"Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol","volume":"81","author":"Ibrahim","year":"2006","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.xkme.2026.101284_bib25","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1600-6143.2008.02237.x","article-title":"Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study","volume":"8","author":"Dabade","year":"2008","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.transproceed.2009.01.042","article-title":"Recurent and de novo membranous glomerulopathy after kidney transplantation","volume":"41","author":"Aline-Fardin","year":"2009","journal-title":"Transplant Proc"},{"issue":"12","key":"10.1016\/j.xkme.2026.101284_bib27","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1111\/j.1600-6143.2009.02851.x","article-title":"Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies","volume":"9","author":"El-Zoghby","year":"2009","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.xkme.2026.101284_bib28","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1093\/ndt\/gfq223","article-title":"Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN)","volume":"25","author":"Moroni","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2215\/CJN.04120609","article-title":"Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation","volume":"5","author":"Sprangers","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2026.101284_bib30","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1111\/j.1600-6143.2011.03643.x","article-title":"Autoantibodies specific for the phospholipase A2 receptor in recurrent and de novo membranous nephropathy","volume":"11","author":"Debiec","year":"2011","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1399-0012.2010.01213.x","article-title":"De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney","volume":"25","author":"Honda","year":"2011","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.xkme.2026.101284_bib32","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1600-6143.2011.03903.x","article-title":"The pathology and clinical features of early recurrent membranous glomerulonephritis","volume":"12","author":"Rodriguez","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.xkme.2026.101284_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/818537","article-title":"Transplant outcomes in patients with idiopathic membranous nephropathy","volume":"2013","author":"Kennedy","year":"2013","journal-title":"Int J Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2026.101284_bib34","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/TP.0b013e31828a947b","article-title":"Phospholipase A2 Receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathy","volume":"95","author":"Larsen","year":"2013","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib35","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/ajt.13133","article-title":"Anti-phospholipase A2 receptor antibodies in recurrent membranous nephropathy","volume":"15","author":"Kattah","year":"2015","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.xkme.2026.101284_bib36","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/TP.0000000000000630","article-title":"Antiphospholipase A2 receptor antibody levels predict the risk of posttransplantation recurrence of membranous nephropathy","volume":"99","author":"Quintana","year":"2015","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000371587","article-title":"Single-dose rituximab for recurrent glomerulonephritis post-renal transplant","volume":"41","author":"Spinner","year":"2015","journal-title":"Am J Nephrol"},{"issue":"37","key":"10.1016\/j.xkme.2026.101284_bib38","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004809","article-title":"HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy","volume":"95","author":"Wen","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"10.1016\/j.xkme.2026.101284_bib39","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1097\/TP.0000000000001056","article-title":"Recurrent membranous nephropathy after kidney transplantation: treatment and long-term implications","volume":"100","author":"Grupper","year":"2016","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.xkme.2026.101284_bib40","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/ctr.12711","article-title":"Pre-transplant phospholipase A2 receptor autoantibody concentration is associated with clinically significant recurrence of membranous nephropathy post-kidney transplantation","volume":"30","author":"Gupta","year":"2016","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib41","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12882-018-1135-7","article-title":"Recurrent glomerulonephritis following renal transplantation and impact on graft survival","volume":"19","author":"Jiang","year":"2018","journal-title":"BMC Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2026.101284_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13738","article-title":"The association of acute rejection vs recurrent glomerular disease with graft outcomes after kidney transplantation","volume":"33","author":"Singh","year":"2019","journal-title":"Clin Transplant"},{"issue":"3","key":"10.1016\/j.xkme.2026.101284_bib43","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.kint.2020.08.007","article-title":"HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients","volume":"99","author":"Berchtold","year":"2021","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.xkme.2026.101284_bib44","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/ckj\/sfad077","article-title":"High exposure to tacrolimus is associated with spontaneous remission of recurrent membranous nephropathy after kidney transplantation","volume":"16","author":"Buxeda","year":"2023","journal-title":"Clin Kidney J"},{"issue":"6","key":"10.1016\/j.xkme.2026.101284_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14970","article-title":"Clinical and histopathologic predictors of recurrent glomerulonephritis after kidney transplantation","volume":"37","author":"Chukwu","year":"2023","journal-title":"Clin Transplant"},{"key":"10.1016\/j.xkme.2026.101284_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fneph.2024.1438065","article-title":"De novo and recurrent post-transplant membranous nephropathy cases show similar rates of concurrent antibody-mediated rejection","volume":"4","author":"Khorsandi","year":"2024","journal-title":"Front Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib47","first-page":"210","article-title":"De novo development of membranous nephropathy in cadaver renal allografts","volume":"9","author":"Steinmuller","year":"1978","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/ki.1982.150","article-title":"De novo membranous nephropathy in human renal allografts: report of nine patients","volume":"22","author":"Cosyns","year":"1982","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0272-6386(89)80189-1","article-title":"De novo membranous glomerulonephropathy in renal allografts: a report of ten cases and review of the literature","volume":"14","author":"Truong","year":"1989","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.xkme.2026.101284_bib50","first-page":"1038","article-title":"Glomerular diseases in human renal allograft","volume":"90","author":"Tsay","year":"1991","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"10.1016\/j.xkme.2026.101284_bib51","first-page":"249","article-title":"Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts","volume":"6","author":"Monga","year":"1993","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.xkme.2026.101284_bib52","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/00007890-199409270-00002","article-title":"Impact of de novo membranous glomerulonephritis on the clinical course after kidney transplantation","volume":"58","author":"Schwarz","year":"1994","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.xkme.2026.101284_bib53","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/oxfordjournals.ndt.a027468","article-title":"Membranous nephropathy: recurrence after kidney transplantation","volume":"11","author":"Marcen","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.xkme.2026.101284_bib54","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1016\/j.transproceed.2011.10.042","article-title":"Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts","volume":"43","author":"Kearney","year":"2011","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-6143.2011.03818.x","article-title":"Increased risk of recurrence of membranous nephropathy after related donor kidney transplantation","volume":"12","author":"Andr\u00e9sd\u00f3ttir","year":"2012","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.xkme.2026.101284_bib56","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/01913123.2013.810682","article-title":"Membranous glomerulopathy in renal allograft: an ultrastructural study of 17 cases","volume":"37","author":"Mart\u00ednez","year":"2013","journal-title":"Ultrastruct Pathol"},{"issue":"12","key":"10.1016\/j.xkme.2026.101284_bib57","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1093\/ndt\/gfu252","article-title":"Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients","volume":"29","author":"Seitz-Polski","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"10.1016\/j.xkme.2026.101284_bib58","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1111\/ajt.13806","article-title":"Temporal IgG subtype changes in recurrent idiopathic membranous nephropathy","volume":"16","author":"Kattah","year":"2016","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib59","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.kint.2016.08.030","article-title":"Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation","volume":"91","author":"Cosio","year":"2017","journal-title":"Kidney Int"},{"issue":"suppl 2","key":"10.1016\/j.xkme.2026.101284_bib60","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/nep.13274","article-title":"Clinicopathological study of de novo membranous nephropathy of \u2018stage 0\u2019 after kidney transplantation","volume":"23","author":"Katsuma","year":"2018","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"10.1016\/j.xkme.2026.101284_bib61","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1053\/j.ajkd.2020.01.009","article-title":"Association of HLA typing and alloimmunity with posttransplantation membranous nephropathy: a multicenter case series","volume":"76","author":"Batal","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ekir.2024.10.012","article-title":"De novo membranous nephropathy in renal allografts is associated with protocadherin FAT1","volume":"10","author":"Al-Rabadi","year":"2025","journal-title":"Kidney Int Rep"},{"issue":"8","key":"10.1016\/j.xkme.2026.101284_bib63","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archinte.1975.00330080103016","article-title":"Recurrence of idiopathic membranous nephropathy in a renal allograft","volume":"135","author":"Crosson","year":"1975","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib64","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/00007890-197707000-00002","article-title":"Recurrent idiopathic membranous glomerulonephritis","volume":"24","author":"Rubin","year":"1977","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib65","first-page":"222","article-title":"Rapid recurrence of membranous nephropathy in a related allograft","volume":"12","author":"Lieberthal","year":"1979","journal-title":"Clin Nephrol"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib66","first-page":"71","article-title":"Membranous nephropathy in a renal allograft. Its occurrence in a patient with previous anti-glomerular basement membrane disease","volume":"105","author":"Grizzle","year":"1981","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib67","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00007890-198208000-00005","article-title":"Immune complexes in a renal allograft with de novo membranous nephropathy","volume":"34","author":"Sugisaki","year":"1982","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib68","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00007890-198507000-00020","article-title":"Recurrent membranous glomerulonephritis in two renal transplants","volume":"40","author":"Obermiller","year":"1985","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.xkme.2026.101284_bib69","first-page":"246","article-title":"Denovo membranous glomerulopathy in renal allograft","volume":"42","author":"Ahmad","year":"1992","journal-title":"J Pak Med Assoc"},{"issue":"3","key":"10.1016\/j.xkme.2026.101284_bib70","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000186781","article-title":"Recurrence of idiopathic membranous nephropathy in HLA-identical allograft","volume":"60","author":"Agarwal","year":"1992","journal-title":"Nephron"},{"issue":"3","key":"10.1016\/j.xkme.2026.101284_bib71","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/ndt\/9.3.323","article-title":"Recurrent membranous nephropathy in successive renal transplants","volume":"9","author":"Innes","year":"1994","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib72","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0272-6386(12)80685-8","article-title":"The recurrence of recurrent membranous glomerulopathy in a renal transplant recipient: case report and literature review","volume":"24","author":"Josephson","year":"1994","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.xkme.2026.101284_bib73","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3346\/jkms.1996.11.4.347","article-title":"An allograft kidney showing both features of IgA nephropathy and membranous glomerulonephritis--a case report","volume":"11","author":"Song","year":"1996","journal-title":"J Korean Med Sci"},{"issue":"7","key":"10.1016\/j.xkme.2026.101284_bib74","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/039139889702000705","article-title":"De novo membranous glomerulopathy in a renal transplant patient treated with FK 506. The first reported case","volume":"20","author":"Lal","year":"1997","journal-title":"Int J Artif Organs"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib75","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000013324","article-title":"Recurrent crescentic membranous nephropathy in two successive renal transplants: association with choroidal effusions and retinal detachment","volume":"18","author":"Lazowski","year":"1998","journal-title":"Am J Nephrol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib76","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0041-1345(99)00941-0","article-title":"Effect of low-density lipoprotein-apheresis on nephrotic syndrome due to membranous nephropathy in renal allograft: a case report","volume":"32","author":"Ideura","year":"2000","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1016\/j.xkme.2026.101284_bib77","first-page":"171","article-title":"De novo membranous glomerulonephritis in a kidney graft recipient","volume":"6","author":"Miserlis","year":"2002","journal-title":"Hippokratia"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib78","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0041-1345(01)02803-2","article-title":"An early case of de novo membranous nephropathy in a renal transplant patient","volume":"34","author":"Teixeira e Costa","year":"2002","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib79","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/joneph\/17.1.134","article-title":"Recurrent membranous nephropathy and leiomyosarcoma in the renal allograft of a lupus patient","volume":"17","author":"Ashfaq","year":"2004","journal-title":"J Nephrol"},{"issue":"12","key":"10.1016\/j.xkme.2026.101284_bib80","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1111\/j.1600-6143.2006.01544.x","article-title":"Anti-CD20 monoclonal antibody (rituximab) for the treatment of recurrent idiopathic membranous nephropathy in a renal transplant patient","volume":"6","author":"Gallon","year":"2006","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.xkme.2026.101284_bib81","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1016\/j.transproceed.2008.03.122","article-title":"Late renal vein thrombosis associated with recurrence of membranous nephropathy in a renal allograft: a case report","volume":"40","author":"Carrasco","year":"2008","journal-title":"Transplant Proc"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib82","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1399-0012.2007.00741.x","article-title":"De novo membranous nephropathy associated with donor-specific alloantibody","volume":"22","author":"El Kossi","year":"2008","journal-title":"Clin Transplant"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib83","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5414\/CNP70419","article-title":"Recurrence and spontaneous remission of membranous nephropathy after renal transplantation","volume":"70","author":"Liebl","year":"2008","journal-title":"Clin Nephrol"},{"issue":"7","key":"10.1016\/j.xkme.2026.101284_bib84","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.transproceed.2008.07.074","article-title":"Anti-CD20 monoclonal antibody (rituximab) for the treatment of membranous nephropathy after living-unrelated kidney transplantation: a case report","volume":"40","author":"Sirimongkolrat","year":"2008","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib85","doi-asserted-by":"crossref","first-page":"373","DOI":"10.5414\/CNP69373","article-title":"Relapse of membranous glomerulopathy after kidney transplantation: sustained remittance induced by rituximab","volume":"69","author":"Weclawiak","year":"2008","journal-title":"Clin Nephrol"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib86","first-page":"395","article-title":"Recurrent idiopathic membranous nephropathy in the renal allograft: Successful treatment with the anti-CD20 monoclonal antibody rituximab","volume":"2","author":"Ladino","year":"2009","journal-title":"NDT Plus"},{"issue":"10","key":"10.1016\/j.xkme.2026.101284_bib87","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1016\/j.transproceed.2010.09.162","article-title":"Nasopharyngeal T-cell monomorphic posttransplant lymphoproliferative disorders and combined IgA nephropathy and membranous glomerulonephritis in a patient with renal transplantation: a case report with literature review","volume":"42","author":"Kfoury","year":"2010","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib88","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMc1003066","article-title":"PLA2R autoantibodies and recurrent membranous nephropathy after transplantation","volume":"363","author":"Stahl","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.xkme.2026.101284_bib89","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1399-0012.2010.01245.x","article-title":"Use of anti-CD20 antibody in the treatment of post-transplant glomerulonephritis","volume":"25","author":"Damodar","year":"2011","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.xkme.2026.101284_bib90","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/j.1600-6143.2011.03957.x","article-title":"Very early recurrence of anti-phospholipase A2 receptor-positive membranous nephropathy after transplantation","volume":"12","author":"Blosser","year":"2012","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.xkme.2026.101284_bib91","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1681\/ASN.2012060577","article-title":"Recurrent membranous nephropathy in an allograft caused by IgG3\u03ba targeting the PLA2 receptor","volume":"23","author":"Debiec","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xkme.2026.101284_bib92","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2369-13-27","article-title":"A complex microdeletion 17q12 phenotype in a patient with recurrent de novo membranous nephropathy","volume":"13","author":"Hinkes","year":"2012","journal-title":"BMC Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2026.101284_bib93","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3109\/0886022X.2012.718952","article-title":"Remission of de novo membranous nephropathy in a kidney allograft recipient: a case report","volume":"34","author":"Okyay","year":"2012","journal-title":"Ren Fail"},{"issue":"6","key":"10.1016\/j.xkme.2026.101284_bib94","doi-asserted-by":"crossref","first-page":"E211","DOI":"10.1111\/tid.12143","article-title":"Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation","volume":"15","author":"Taton","year":"2013","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib95","first-page":"158","article-title":"Recurrent idiopathic membranous glomerulonephritis after kidney transplantation and successful treatment with rituximab","volume":"9","author":"Makhdoomi","year":"2015","journal-title":"Iran J Kidney Dis"},{"issue":"suppl 2","key":"10.1016\/j.xkme.2026.101284_bib96","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/nep.12458","article-title":"Phospholipase A2 receptor positive membranous nephropathy long after living donor kidney transplantation between identical twins","volume":"20","author":"Saito","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"10.1016\/j.xkme.2026.101284_bib97","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2169\/internalmedicine.55.5468","article-title":"Post-transplant membranous nephropathy associated with chronic active antibody-mediated rejection and hepatitis C infection after deceased donor renal transplantation","volume":"55","author":"Doke","year":"2016","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.xkme.2026.101284_bib98","first-page":"350","article-title":"Bortezomib as a novel approach to early recurrent membranous glomerulonephritis after kidney transplant refractory to combined conventional rituximab therapy","volume":"15","author":"Barbari","year":"2017","journal-title":"Exp Clin Transplant"},{"issue":"8","key":"10.1016\/j.xkme.2026.101284_bib99","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.transproceed.2018.03.083","article-title":"Recurrent membranous nephropathy after kidney transplantation associated with phospholipase A2 receptor and successfully treated with rituximab: a case report","volume":"50","author":"Ishiwatari","year":"2018","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.xkme.2026.101284_bib100","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4103\/1319-2442.235186","article-title":"Recurrence of membranous nephropathy three weeks\u2019 postrenal transplant: a surprise in store","volume":"29","author":"Kumar","year":"2018","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib101","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12959","article-title":"Recurrent membranous nephropathy and acute cellular rejection in a patient treated with direct anti-HCV therapy (ledipasvir\/sofosbuvir)","volume":"20","author":"Murakami","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.xkme.2026.101284_bib102","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/17843286.2017.1361622","article-title":"Intravenous immunoglobulins modify relapsing membranous glomerulonephritis after kidney transplantation: a case report","volume":"73","author":"Steyaert","year":"2018","journal-title":"Acta Clin Belg"},{"issue":"9","key":"10.1016\/j.xkme.2026.101284_bib103","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1111\/ajt.16610","article-title":"Posttransplant nephrotic syndrome resulting from NELL1-positive membranous nephropathy","volume":"21","author":"M\u00fcnch","year":"2021","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib104","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5500\/wjt.v12.i1.15","article-title":"Is de novo membranous nephropathy suggestive of alloimmunity in renal transplantation? A case report","volume":"12","author":"Darji","year":"2022","journal-title":"World J Transplant"},{"issue":"7","key":"10.1016\/j.xkme.2026.101284_bib105","doi-asserted-by":"crossref","first-page":"695","DOI":"10.6002\/ect.2022.0146","article-title":"Rituximab administered for recurrent membranous nephropathy in a kidney transplant recipient did not eliminate donor-specific antibodies","volume":"20","author":"Giannopoulou","year":"2022","journal-title":"Exp Clin Transplant"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib106","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/ijot.ijot_109_21","article-title":"Posttransplant membranous nephropathy - a case report","volume":"16","author":"Sullaiman","year":"2022","journal-title":"Indian J Transpl"},{"issue":"suppl 2","key":"10.1016\/j.xkme.2026.101284_bib107","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nefroe.2022.09.005","article-title":"THSD7A-positive membranous nephropathy after kidney transplantation: a case report","volume":"43","author":"Sol\u00e0-Porta","year":"2023","journal-title":"Nefrologia (Engl Ed)"},{"issue":"6","key":"10.1016\/j.xkme.2026.101284_bib108","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s13730-024-00864-4","article-title":"De novo posttransplant membranous nephropathy after COVID-19 vaccination 9 years after renal transplantation in a patient with polycystic kidney disease","volume":"13","author":"Fukuda","year":"2024","journal-title":"CEN Case Rep"},{"issue":"9","key":"10.1016\/j.xkme.2026.101284_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100876","article-title":"Complement receptor 1 enhancement in recurrent membranous nephropathy following kidney transplantation: a case report","volume":"6","author":"Kounoue","year":"2024","journal-title":"Kidney Med"},{"issue":"7","key":"10.1016\/j.xkme.2026.101284_bib110","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1007\/s40620-025-02224-6","article-title":"Obinutuzumab in rituximab-resistant and recurrent membranous nephropathy: a case-series","volume":"38","author":"Sridharan","year":"2025","journal-title":"J Nephrol"},{"issue":"11","key":"10.1016\/j.xkme.2026.101284_bib111","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2215\/CJN.00280121","article-title":"Recurrent glomerular disease after kidney transplantation: diagnostic and management dilemmas","volume":"16","author":"Uffing","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.xkme.2026.101284_bib112","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1097\/TP.0000000000002758","article-title":"Membranous nephropathy posttransplantation: an update of the pathophysiology and management","volume":"103","author":"Leon","year":"2019","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.xkme.2026.101284_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103805","article-title":"Immunosenescence in autoimmune diseases","volume":"24","author":"Hu","year":"2025","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib114","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2023.2201341","article-title":"Incidence and risk factors for recurrent focal segmental glomerulosclerosis after kidney transplantation: a meta-analysis","volume":"45","author":"Bai","year":"2023","journal-title":"Ren Fail"},{"issue":"7","key":"10.1016\/j.xkme.2026.101284_bib115","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/toxins12070439","article-title":"Immune dysfunction in uremia 2020","volume":"12","author":"Cohen","year":"2020","journal-title":"Toxins (Basel)"},{"issue":"7","key":"10.1016\/j.xkme.2026.101284_bib116","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA2R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"Stanescu","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib117","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1681\/ASN.2016020114","article-title":"MHC class II risk alleles and amino acid residues in idiopathic membranous nephropathy","volume":"28","author":"Cui","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"pt 1","key":"10.1016\/j.xkme.2026.101284_bib118","article-title":"Exploring PLA2R and HLA in membranous nephropathy: a narrative review of pathogenic mechanisms and emerging therapeutic potentials","volume":"280","author":"Zhang","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"10.1016\/j.xkme.2026.101284_bib119","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.1038\/s41598-025-91366-5","article-title":"Role of PLA2R domain antibodies and epitope spreading in risk stratification and prediction of proteinuria remission in primary membranous nephropathy","volume":"15","author":"Zhang","year":"2025","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.xkme.2026.101284_bib120","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1681\/ASN.2014111061","article-title":"Epitope spreading of autoantibody response to PLA2R associates with poor prognosis in membranous nephropathy","volume":"27","author":"Seitz-Polski","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.xkme.2026.101284_bib121","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1097\/TP.0000000000000962","article-title":"Long-term kidney transplant outcomes in primary glomerulonephritis: analysis from the ERA-EDTA registry","volume":"100","author":"Pippias","year":"2016","journal-title":"Transplantation"},{"issue":"4S","key":"10.1016\/j.xkme.2026.101284_bib122","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.xkme.2026.101284_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100822","article-title":"Pretransplant treatment to avoid recurrent membranous nephropathy in a kidney transplant recipient: a case report","volume":"6","author":"Lum","year":"2024","journal-title":"Kidney Med"},{"issue":"11","key":"10.1016\/j.xkme.2026.101284_bib124","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1016\/j.ekir.2024.09.009","article-title":"De novo exostosin-associated membranous nephropathy in kidney transplant","volume":"9","author":"Lafaut","year":"2024","journal-title":"Kidney Int Rep"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.34067\/KID.0000000000000323","article-title":"Early steroid withdrawal in kidney transplant recipients: CON","volume":"6","author":"Aziz","year":"2025","journal-title":"Kidney360"},{"key":"10.1016\/j.xkme.2026.101284_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpg.2021.101756","article-title":"Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology","volume":"54-55","author":"Udomkarnjananun","year":"2021","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"10.1016\/j.xkme.2026.101284_bib127","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-3083.1991.tb03747.x","article-title":"Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice","volume":"33","author":"Eugui","year":"1991","journal-title":"Scand J Immunol"}],"container-title":["Kidney Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526000452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590059526000452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:49:36Z","timestamp":1777312176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590059526000452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2590059526000452"],"URL":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101284","relation":{},"ISSN":["2590-0595"],"issn-type":[{"value":"2590-0595","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent, Nonrecurrent, and De Novo Membranous Nephropathy After Kidney Transplantation: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Kidney Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xkme.2026.101284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101284"}}